Page last updated: 2024-08-24

glucuronic acid and nutlin-3a

glucuronic acid has been researched along with nutlin-3a in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Apter, L; Barenholz, Y; Haupt, S; Haupt, Y; Minko, T; Nadler-Milbauer, M; Rubinstein, A	1

Other Studies

1 other study(ies) available for glucuronic acid and nutlin-3a

Article	Year
Synchronized release of Doxil and Nutlin-3 by remote degradation of polysaccharide matrices and its possible use in the local treatment of colorectal cancer. Journal of drug targeting, 2011, Volume: 19, Issue:10 Topics: Alginates; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cross-Linking Reagents; Cyclin-Dependent Kinase Inhibitor p21; Delayed-Action Preparations; Doxorubicin; Gene Expression Regulation, Neoplastic; Glucuronic Acid; Hexuronic Acids; HT29 Cells; Humans; Imidazoles; Piperazines; Tumor Suppressor Protein p53	2011

Article

Year

Synchronized release of Doxil and Nutlin-3 by remote degradation of polysaccharide matrices and its possible use in the local treatment of colorectal cancer.

Journal of drug targeting, 2011, Volume: 19, Issue:10

Topics: Alginates; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cross-Linking Reagents; Cyclin-Dependent Kinase Inhibitor p21; Delayed-Action Preparations; Doxorubicin; Gene Expression Regulation, Neoplastic; Glucuronic Acid; Hexuronic Acids; HT29 Cells; Humans; Imidazoles; Piperazines; Tumor Suppressor Protein p53

2011